Metraipolis › archive › dc_fb6dd2009a33

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients — Europe PMC PMID:42338005

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42338005
DOI
10.1002/ijc.70584
License (as archived)
solo-consultazione
Archived
2026-10-19T05:39:32.125Z
SHA-256 of the archived text
3fe3a85a53c54fa48f4e5d9e451ea87bcbf5daa1607c5591999d4188ee5d5c36
Stable URL of this page
https://metraipolis.com/documento/dc_fb6dd2009a33

How to cite

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients — Europe PMC PMID:42338005 — Europe PMC (en), https://europepmc.org/article/MED/42338005 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb6dd2009a33 (Metraipolis archive dc_fb6dd2009a33, sha256 3fe3a85a53c54fa48f4e5d9e451ea87bcbf5daa1607c5591999d4188ee5d5c36)
BibTeX
@misc{dcfb6dd2009a33,
  title = {A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients — Europe PMC PMID:42338005},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42338005},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb6dd2009a33; sha256 3fe3a85a53c54fa48f4e5d9e451ea87bcbf5daa1607c5591999d4188ee5d5c36},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42338005. Agents can read the archived copy with the MCP tool read_document.